[1]
“IN VIVO EVALUATION OF TAZAROTENE SOLID LIPID NANOPARTICLES GEL FOR TOPICAL DELIVERY”, Int. J. Pharm. Sci. Drug Res., vol. 11, no. 1, pp. 45–50, Jan. 2019, doi: 10.25004/IJPSDR.2019.110107.